Compare · TMDX vs VANI
TMDX vs VANI
Side-by-side comparison of TransMedics Group Inc. (TMDX) and Vivani Medical Inc. (VANI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both TMDX and VANI operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- TMDX is the larger of the two at $2.65B, about 25.6x VANI ($103.7M).
- Over the past year, TMDX is down 40.9% and VANI is down 39.4% - VANI leads by 1.6 points.
- TMDX has been more active in the news (2 items in the past 4 weeks vs 1 for VANI).
- TMDX has more recent analyst coverage (20 ratings vs 0 for VANI).
- Company
- TransMedics Group Inc.
- Vivani Medical Inc.
- Price
- $70.82-7.52%
- $1.14-0.87%
- Market cap
- $2.65B
- $103.7M
- 1M return
- -18.36%
- -6.17%
- 1Y return
- -40.92%
- -39.36%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2014
- News (4w)
- 2
- 1
- Recent ratings
- 20
- 0
TransMedics Group Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Latest TMDX
- Barclays initiated coverage on TransMedics Group with a new price target
- SEC Form 3 filed by new insider Araujo Fernando N.
- Director Weill David bought $109,058 worth of shares (1,336 units at $81.63), increasing direct ownership by 9% to 16,392 units (SEC Form 4)
- TransMedics Group Inc. filed SEC Form 8-K: Regulation FD Disclosure
- TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook
- TransMedics to Present at Upcoming September Investor Conferences
- Director Tobin James R gifted 18,000 shares (SEC Form 4)
- SEC Form 10-Q filed by TransMedics Group Inc.
- TransMedics Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- TransMedics Reports Second Quarter 2026 Financial Results
Latest VANI
- Vivani Medical Announces Participation in Upcoming Investor Conferences
- SEC Form 424B5 filed by Vivani Medical Inc.
- Vivani Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Vivani Medical Announces Participation in Upcoming Investor Conferences
- Vivani Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Vivani Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
- SEC Form 10-Q filed by Vivani Medical Inc.
- Why Investors Are Watching These Healthcare Movers
- Vivani Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits